Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000196960 | SCV000250068 | uncertain significance | not specified | 2014-12-08 | criteria provided, single submitter | clinical testing | The c.1591_1592delGCinsTT variant in the ELN gene has not been reported previously as a disease-causing mutation nor as a benign polymorphism, to our knowledge. It results in substitution of the Alanine 531 residue with a Phenylalanine residue, denoted A531F at the protein level. The c.1591_1592delGCinsTT variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The variant results in a semi-conservative amino acid substitution, may impact secondary protein structure as these residues differ in some properties. It occurs at a position that is well conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret c.1591_1592delGCinsTT as a variant of unknown significance. This variant was found in ELN |
Fulgent Genetics, |
RCV002478682 | SCV002788011 | uncertain significance | Cutis laxa, autosomal dominant 1; Williams syndrome; Supravalvar aortic stenosis | 2022-02-24 | criteria provided, single submitter | clinical testing |